Browsing by Author Carlos, Giuliana R M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Citation
2016Accuracy of optical coherence tomography for the diagnosis of superficial basal cell carcinoma: a prospective, consecutive, cohort study of 168 casesCarlos, Giuliana R M; Cheng, H; Guitera, Pascale; Lo, Serigne; Scolyer, Richard; Meekings, A; Western Clinical School: Medicine (Westmead); Medicine; Melanoma Foundation; The George Institute for Global Health; Central Clinical School: PathologyAccuracy of optical coherence tomography for the diagnosis of superficial basal cell carcinoma: a prospective, consecutive, cohort study of 168 cases, British Journal of Dermatology, vol.175, 6, 2016,pp 1290-1300
2016Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohortByth Wilson, Karen; Carlino, Matteo; Carlos, Giuliana R M; Fernandez Penas, Pablo; Hwang, Shelley; Wakade, Deepal; Chou, Shaun; Kefford, Richard F; Kong, Benjamin; NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort, Journal Of The American Academy Of Dermatology, vol.74, 3, 2016,pp 455-461
2015Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeksAnforth, Rachael; Carlos, Giuliana R M; Clements, Arthur; Fernandez Penas, Pablo; Kefford, Richard (Rick); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteCutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks, British Journal of Dermatology, vol.172, 1, 2015,pp 239-243
2015Cutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic MelanomaAnforth, Rachael; Carlino, Matteo; Carlos, Giuliana R M; Clements, Arthur; Fernandez Penas, Pablo; Menzies, Alexander Maxwel; Chou, Shaun; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineCutaneous Toxic Effects of BRAF Inhibitors Alone and in Combination With MEK Inhibitors for Metastatic Melanoma, JAMA Dermatology, vol.151, 10, 2015,pp 1103-1109
2015Eruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanomaAnforth, Rachael; Carlos, Giuliana R M; Fernandez Penas, Pablo; Scolyer, Richard; Chou, Shaun; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyEruptive naevi in a patient treated with LGX818 for BRAF mutant metastatic melanoma, Melanoma Research, vol.25, 1, 2015,pp 91-94
2015Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapyAnforth, Rachael; Byth Wilson, Karen; Carlos, Giuliana R M; Fernandez Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Menzies, Alexander Maxwel; Scolyer, Richard; Sharma, Raghwa; Chou, Shaun; Western Clinical School: Medicine (Westmead); NH&MRC Clinical Trials Centre; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Pathology; Western Clinical School: PathologyFactors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy, Journal Of The American Academy Of Dermatology, vol.72, 5, 2015,pp 809-815.e1